ECKERT & ZIEGLER SE (EUZ.DE) Stock Fundamental Analysis
FRA:EUZ - Deutsche Boerse Ag - DE0005659700 - Common Stock - Currency: EUR
We assign a fundamental rating of 7 out of 10 to EUZ. EUZ was compared to 58 industry peers in the Health Care Equipment & Supplies industry. EUZ has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EUZ is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, EUZ could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year EUZ was profitable.
In the past year EUZ had a positive cash flow from operations.
Each year in the past 5 years EUZ has been profitable.
In the past 5 years EUZ always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of EUZ (7.63%) is better than 81.03% of its industry peers.
EUZ has a Return On Equity of 14.94%. This is amongst the best in the industry. EUZ outperforms 84.48% of its industry peers.
EUZ's Return On Invested Capital of 12.03% is amongst the best of the industry. EUZ outperforms 93.10% of its industry peers.
EUZ had an Average Return On Invested Capital over the past 3 years of 9.92%. This is in line with the industry average of 8.02%.
The 3 year average ROIC (9.92%) for EUZ is below the current ROIC(12.03%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 14.94% | ||
| ROIC | 12.03% |
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
1.3 Margins
The Profit Margin of EUZ (11.63%) is better than 77.59% of its industry peers.
EUZ's Profit Margin has declined in the last couple of years.
EUZ has a Operating Margin of 21.36%. This is amongst the best in the industry. EUZ outperforms 86.21% of its industry peers.
In the last couple of years the Operating Margin of EUZ has grown nicely.
EUZ has a Gross Margin of 47.98%. This is comparable to the rest of the industry: EUZ outperforms 43.10% of its industry peers.
EUZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.36% | ||
| PM (TTM) | 11.63% | ||
| GM | 47.98% |
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
2. Health
2.1 Basic Checks
EUZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for EUZ remains at a similar level compared to 1 year ago.
Compared to 5 years ago, EUZ has more shares outstanding
EUZ has a better debt/assets ratio than last year.
2.2 Solvency
EUZ has an Altman-Z score of 5.81. This indicates that EUZ is financially healthy and has little risk of bankruptcy at the moment.
EUZ has a better Altman-Z score (5.81) than 84.48% of its industry peers.
The Debt to FCF ratio of EUZ is 1.02, which is an excellent value as it means it would take EUZ, only 1.02 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.02, EUZ belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
EUZ has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of EUZ (0.19) is better than 68.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.02 | ||
| Altman-Z | 5.81 |
ROIC/WACC1.72
WACC6.99%
2.3 Liquidity
EUZ has a Current Ratio of 3.08. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
EUZ's Current ratio of 3.08 is fine compared to the rest of the industry. EUZ outperforms 79.31% of its industry peers.
EUZ has a Quick Ratio of 2.46. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.46, EUZ belongs to the best of the industry, outperforming 81.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.08 | ||
| Quick Ratio | 2.46 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.59% over the past year.
EUZ shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.20% yearly.
The Revenue has grown by 15.89% in the past year. This is quite good.
Measured over the past years, EUZ shows a quite strong growth in Revenue. The Revenue has been growing by 10.63% on average per year.
EPS 1Y (TTM)14.59%
EPS 3Y-1.5%
EPS 5Y8.2%
EPS Q2Q%15.88%
Revenue 1Y (TTM)15.89%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%0.85%
3.2 Future
EUZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.72% yearly.
Based on estimates for the next years, EUZ will show a quite strong growth in Revenue. The Revenue will grow by 9.18% on average per year.
EPS Next Y25%
EPS Next 2Y17.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.94%
Revenue Next 2Y9.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 40.83, EUZ can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of EUZ is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.21, EUZ is valued quite expensively.
A Price/Forward Earnings ratio of 25.84 indicates a quite expensive valuation of EUZ.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EUZ is on the same level as its industry peers.
EUZ's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.83 | ||
| Fwd PE | 25.84 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EUZ is valued a bit cheaper than 65.52% of the companies in the same industry.
75.86% of the companies in the same industry are more expensive than EUZ, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27 | ||
| EV/EBITDA | 16.28 |
4.3 Compensation for Growth
EUZ's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of EUZ may justify a higher PE ratio.
A more expensive valuation may be justified as EUZ's earnings are expected to grow with 17.72% in the coming years.
PEG (NY)1.63
PEG (5Y)4.98
EPS Next 2Y17.72%
EPS Next 3YN/A
5. Dividend
5.1 Amount
EUZ has a yearly dividend return of 0.75%, which is pretty low.
Compared to an average industry Dividend Yield of 2.07, EUZ pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.75, EUZ pays less dividend than the S&P500 average, which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.75% |
5.2 History
The dividend of EUZ decreases each year by -30.23%.
Dividend Growth(5Y)-30.23%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
3.02% of the earnings are spent on dividend by EUZ. This is a low number and sustainable payout ratio.
DP3.02%
EPS Next 2Y17.72%
EPS Next 3YN/A
FRA:EUZ (7/2/2025, 5:29:49 PM)
66.55
+0.25 (+0.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.96%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap1.41B
Analysts80
Price Target68.9 (3.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.75% |
Yearly Dividend0.05
Dividend Growth(5Y)-30.23%
DP3.02%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.97%
PT rev (3m)6.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.83 | ||
| Fwd PE | 25.84 | ||
| P/S | 4.75 | ||
| P/FCF | 27 | ||
| P/OCF | 20.14 | ||
| P/B | 6.1 | ||
| P/tB | 7.74 | ||
| EV/EBITDA | 16.28 |
EPS(TTM)1.63
EY2.45%
EPS(NY)2.58
Fwd EY3.87%
FCF(TTM)2.46
FCFY3.7%
OCF(TTM)3.3
OCFY4.96%
SpS14
BVpS10.9
TBVpS8.6
PEG (NY)1.63
PEG (5Y)4.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 14.94% | ||
| ROCE | 16.94% | ||
| ROIC | 12.03% | ||
| ROICexc | 17.6% | ||
| ROICexgc | 21.76% | ||
| OM | 21.36% | ||
| PM (TTM) | 11.63% | ||
| GM | 47.98% | ||
| FCFM | 17.6% |
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
ROICexc(3y)13.44%
ROICexc(5y)13%
ROICexgc(3y)17.78%
ROICexgc(5y)17.59%
ROCE(3y)13.96%
ROCE(5y)12.89%
ROICexcg growth 3Y11.22%
ROICexcg growth 5Y1.55%
ROICexc growth 3Y17.53%
ROICexc growth 5Y5.68%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
F-Score7
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.02 | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 94.14% | ||
| Cap/Sales | 5.99% | ||
| Interest Coverage | 59.68 | ||
| Cash Conversion | 85.09% | ||
| Profit Quality | 151.32% | ||
| Current Ratio | 3.08 | ||
| Quick Ratio | 2.46 | ||
| Altman-Z | 5.81 |
F-Score7
WACC6.99%
ROIC/WACC1.72
Cap/Depr(3y)190.39%
Cap/Depr(5y)187.58%
Cap/Sales(3y)10.17%
Cap/Sales(5y)10.1%
Profit Quality(3y)67.54%
Profit Quality(5y)69.62%
High Growth Momentum
Growth
EPS 1Y (TTM)14.59%
EPS 3Y-1.5%
EPS 5Y8.2%
EPS Q2Q%15.88%
EPS Next Y25%
EPS Next 2Y17.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.89%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%0.85%
Revenue Next Year8.94%
Revenue Next 2Y9.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.39%
EBIT growth 3Y28.59%
EBIT growth 5Y16.95%
EBIT Next Year57.03%
EBIT Next 3Y19.41%
EBIT Next 5YN/A
FCF growth 1Y989.46%
FCF growth 3Y114.55%
FCF growth 5Y8.28%
OCF growth 1Y101.64%
OCF growth 3Y25.28%
OCF growth 5Y10.49%